-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

624.P1.38 624. Hodgkin Lymphomas: Clinical and Epidemiological: Poster I

Symposia: Hodgkin Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Fjoralba Kristo1*, Flora Mazerolle2*, Thibaud Alin2*, Antoine Regnault2*, Justin Ferdinandus, MD3*, Karolin Behringer3*, Janina Jablonski3*, Peter Borchmann, MD3 and Ajibade Ashaye, MD, MS, MBA, MPH1

1Takeda Development Center Americas, Inc., Cambridge, MA
2Modus Outcomes, a THREAD company, Lyon, France
3German Hodgkin Study Group and Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Cologne, Germany

Maria Carmen Martinez Munoz, MD, PhD1*, Irma Khvedelidze2*, Mathilde Fekom3*, Benedicte Deau Fischer, MD4*, Amira Marouf5*, Herve Ghesquieres, MD, PhD6*, Luc-Matthieu Fornecker, MD, PhD7*, Francesco Merli8*, Piero Maria Stefani, MD9*, Fulvio Massaro10*, Barbara Botto11*, A. Burhan Ferhanoglu, MD12, Olga Meltem Akay13*, Murat Ozbalak, MD14*, Manuel Espeso De Haro15*, Samuel Romero, MD16*, Jaques-Emmanuel Galimard17*, Bertram Glass, MD18*, Ali Bazarbachi, MD, PhD19 and Anna Sureda Balari20

1Hematopoietic Cell Transplant Unit, Hospital Clinic of Barcelona, ICAMS, Barcelona, Spain
2EBMT Paris Study Unit, Paris, France
3European Bone Marrow Transplantation Lymphoma Working Party, Paris, France
4Department of Hematology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, FRA
5INSERM UMR U1163—Imagine Institute, Paris, France
6Department of Hematology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France
7Institut De Cancérologie Strasbourg Europe, Hematology Department, Strasbourg, France
8Hematology Department, AZIENDA USL-IRCCS DI REGGIO EMILIA, Reggio Emilia, Italy
9Struttura Complessa di Ematologia Dipartimento Strutturale di Medicina Interna, Presidio Ospedaliero di Treviso AULSS2 Marca Trevigiana, Treviso, Italy
10Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium
11Division of Hematology, Città della Salute e della Scienza Hospital and University, Torino, Italy
12Koç University Medical Faculty, Istanbul, Turkey
13Koç University Medical Faculty, Istambul, Turkey
14Istanbul University, Istanbul Medical Faculty, Istanbul, Turkey
15Hospital Regional Universitario de Málaga, MALAGA, Spain
16Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
17EBMT Lymphoma Working Party, Paris, France
18Department of Hematology and Stem Cell Transplantation, Helios Klinikum Berlin-Buch, Berlin, Germany
19American University of Beirut Dept. of Medicine, Beirut, Lebanon
20Instituto Catalán de Oncología - Hospital Duran i Reynals, Barcelona, Spain

Pamela B. Allen, MD1, Latifa Bazzi, PhD2*, Bin Zhang, MD, PhD3*, Qing Chen, MD, PhD4*, Liron Barnea Slonim, MD4*, Hatice Savas, MD5*, Ranjana H. Advani, MD6, Andrew M Evens, DO MBA MSc7, Barbara Pro, MD8, Reem Karmali, MD9, Eric Mou, MD10*, Robert Eisner, DO11, Robert Bayer, MD11*, Leo I. Gordon, MD12 and Jane N. Winter, MD13*

1Department of Hematology, Emory University School of Medicine, Decatur, GA
2Biostatistics, Northwestern, Chicago, IL
3Department of Medicine, Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL
4Pathology, Northwestern, Chicago, IL
5Radiology, Northwestern, Chicago, IL
6Department of Medicine, Division of Oncology and Hematology, Stanford University, Stanford, CA
7Rutgers Cancer Institute, New Brunswick, NJ
8Lymphoma Program, Division of Hematology & Oncology, Columbia University, New York, NY
9Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
10Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
11Feinberg School of Medicine, Northwestern University, Chicago, IL
12Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
13Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL

Antonio Vega Mateos, MD1, Héctor Alejandro Vaquera Alfaro, MD2, Ana Cristina Tejada Vasquez, MD2, Yadith Karina Lopez-Garcia, MD1, Gerardo Garcia-Salas, MD2, Olga Cantu, MD2*, Andres Gomez-De Leon, MD2, David Gomez-Almaguer, MD2, Luz Tarin-Arzaga, MD2*, César Homero Gutierrez-Aguirre, MD2* and Perla R. Colunga-Pedraza, MD2

1Servicio de Hematología, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autónoma de Nuevo León, Monterrey, Mexico
2Servicio de Hematología, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autónoma de Nuevo León, Monterrey, NL, Mexico

Thomas M Kuczmarski, MD1, Chaitra S. Ujjani, MD2, Christina Poh, MD3, Edus H. Warren, MD, PhD1, Stephen D. Smith, MD1, Mazyar Shadman, MD, MPH3, Brian G. Till, MD4, Vikram Raghunathan, MD1*, Yolanda D Tseng, MD5*, Hongyan Du3*, Jacquelin Vandermeer, BS3*, Alyssa Kelly3*, Heather Rasmussen3*, Jenna M. Voutsinas, MPH6*, Ajay K. Gopal, MD7 and Ryan C Lynch, MD3

1Division of Hematology and Oncology, University of Washington, Seattle, WA
2Clinical Research Division, Fred Hutch Cancer Center; and Division of Oncology, University of Washington, Seattle, WA
3Fred Hutchinson Cancer Center, Seattle, WA
4Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
5Department of Radiation Oncology, University of Washington and Fred Hutch Cancer Center, Seattle, WA
6Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
7University of Washington, Seattle, WA

Thomas M Kuczmarski, MD1, Chaitra S. Ujjani, MD2, Christina Poh, MD3, Edus H. Warren, MD, PhD1, Stephen D. Smith, MD1,3, Mazyar Shadman, MD, MPH3, Brian G. Till, MD4, Vikram Raghunathan, MD1*, Yolanda D Tseng, MD5*, Hongyan Du3*, Jacquelin Vandermeer, BS3*, Alyssa Kelly3*, Heather Rasmussen3*, Jenna M. Voutsinas, MPH6*, Ajay K. Gopal, MD7 and Ryan C Lynch, MD3

1Division of Hematology and Oncology, University of Washington, Seattle, WA
2Clinical Research Division, Fred Hutch Cancer Center; and Division of Oncology, University of Washington, Seattle, WA
3Fred Hutchinson Cancer Center, Seattle, WA
4Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
5Department of Radiation Oncology, University of Washington and Fred Hutch Cancer Center, Seattle, WA
6Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
7University of Washington, Seattle, WA

Efrat Luttwak, MD1, Swetha Kambhampati Thiruvengadam, MD2, Esther Drill, DrPH3*, Nivetha Ganesan, MPH3*, Liron Hofstetter4*, Ronit Gurion5*, Shlomzion Aumann, MD6,7*, Arnon Haran8,9*, Mika Geva10, Marc Panossian11,12*, Robert Stuver, MD1, Paul A. Hamlin, MD1, Ariela Noy, MD13, Alex F. Herrera, MD14 and Alison Moskowitz, MD1

1Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2City of Hope National Medical Center, Yorba Linda, CA
3Memorial Sloan Kettering Cancer Center, New York, NY
4Faculty of Medicine, Tel Aviv University, Petah Tikva, Israel
5Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel
6Department of Hematology, Hadassah Medical Center, Jerusalem, Israel
7Hebrew University, Jerusalem, Israel
8Department of Hematology, Hadassah Hebrew University Medical Center, Jerusalem, Israel
9Department of Hematology, Hadassah Medical Center, Mevaseret Zion, Israel
10Sheba medical center, Ramat Gan, Israel
11City of Hope, Durate, CA
12UCLA, Westwood, CA
13Memorial Sloan-Kettering Cancer Ctr., New York, NY
14City of Hope, Duarte, CA

Reid W. Merryman, MD1, Justin Kline, MD2, Robert A. Redd, MS3*, Emma L. Welsh, BE4*, Kathleen Pfaff, PhD4*, Hannah Juhaie Lee1*, Mikaela M. McDonough5*, Inhye E. Ahn, MD1, Jennifer R. Brown, MD, PhD6, Jennifer L. Crombie, MD1, Matthew S. Davids, MD, MMSc1, David C. Fisher, MD1, Eric D. Jacobsen, MD7, Caron A. Jacobson, MD, MMSc1, Austin I. Kim, MD5, Oreofe O. Odejide, MD1, Erin M. Parry, MD, PhD1, Christine E. Ryan, MD1, Margaret A. Shipp, MD1, Philippe Armand, MD, PhD1, Scott J. Rodig, MD, PhD4, Jeremy S. Abramson, MD8 and Ann S. LaCasce, MD, MMSc5

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Department of Medicine, Section of Hematology/Oncology, University of Chicago Medicine, Chicago, IL
3Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
4Department of Pathology, Brigham and Women's Hospital, Boston, MA
5Dana-Farber Cancer Institute, Boston, MA
6Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
7Dana Farber Cancer Institute, Boston, MA
8Massachusetts General Hospital Cancer Center, Boston, MA

Angelo Rizzolo, MD1, Noah Ben-Ezra, MD2*, Richard Liu, MD2*, Matthew Salaciak, M.Sc.3*, Peter Maliha, MD4*, Stephan Probst, MD2* and Nathalie A. Johnson, MD, PhD,5

1Division of Hematology, Jewish General Hospital, Montreal, QC, Canada
2Division of Nuclear Medicine, Jewish General Hospital, Montreal, QC, Canada
3Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada
4Nuclear Medicine, Centre Hospitalier de l’Université de Montréal Centre de Recherche, Université de Montréal, Montreal, QC, Canada
5Jewish General Hospital, Montreal, QC, Canada

Cong Sun1*, Xianhuo Wang, MD2* and Huilai Zhang, MD3

1Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
2Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
3Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China

Ariel Perez Perez, MD1, Nayef Abdel-Razeq, MD2*, Tiba Al Sagheer, PharmD1*, George Nahas, DO1, Jose Sandoval-Sus, MD3, Manny Alfonso, PharmD3*, Carlos Silva, MD3, Syeda Saba Kareem, PharmD4*, Katherine Tobon, PharmD, BS4*, Allison C. Rosenthal, DO5, Stephen M. Ansell, MD, PhD6, Yuliya PL Linhares, MD1, Muhamad Alhaj Moustafa, M.D., M.S.2 and Hayder Saeed, MD4

1Blood and Marrow Transplant Program, Miami Cancer Institute, Baptist Health South Florida, Miami, FL
2Division of Hematology, Mayo Clinic, Jacksonville, FL
3Moffitt Cancer Center at Memorial Healthcare System, Pembroke Pines, FL
4Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
5Division of Hematology/Oncology Mayo Clinic, Phoenix, AZ
6Division of Hematology, Mayo Clinic, Rochester, MN

Hala Hassanain, MD1,2*, Ethan A Burns, MD3, Sunil Mathur3*, Darshil Choksi4*, Cesar Giancarlo Gentille Sanchez, MD5, Chih-Chi Andrew Hu, PhD6, Mai Hanh3*, Carrie Yuen, MD3*, Shilpan S. Shah, MD3*, Siddhartha Ganguly, MD7 and Sai Ravi Kiran Pingali, MD3

1Internal Medicine, Department of Academic Medicine, Houston, TX
2Academy of Physician Scientists, Texas A&M, Houston
3Houston Methodist Neal Cancer Center, Houston Methodist Hospital, Houston, TX
4Dell Medical School, Austin, TX
5University of Arkansas for Medical Sciences, Little Rock, AR
6Houston Methodist Research Institute, Houston, TX
7Houston Methodist Hospital, Houston, TX

Yuqin Song, MD1, Qingsong Yin, PhD2*, Zhiming Li, PhD, MD3, Jingye Meng4*, Yan Yan5*, Mengli Zhou5*, Wenyi Sun5*, Kezhen Liu5* and Jun Zhu, PhD1

1Peking University Cancer Hospital, Beijing, China
2Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
3Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
4Shenzhen Third People's Hospital, shenzhen, China
5Shanghai Fudan-Zhangjiang Bio-pharmaceutical Co., Ltd, Shanghai, China

Alex F. Herrera, MD1, Swetha Kambhampati Thiruvengadam, MD1, Michael A Spinner, MD2, Christina Poh, MD3, Elizabeth H. Phillips4*, Vincent Ribrag, MD5, Ming Jin Yan6*, Tara Chen, PharmD6 and Julie M. Vose, MD, MBA7

1City of Hope, Duarte, CA
2University of California San Francisco, San Francisco, CA
3Fred Hutchinson Cancer Center, Seattle, WA
4Division of Cancer Sciences, University of Manchester, The Christie NHS Foundation Trust, Manchester, United Kingdom
5Institut Gustave Roussy, Villejuif, France
6Pfizer Inc, Bothell, WA
7Department of Hematology and Oncology, University of Nebraska Medical Center, Omaha, NE

Tae Min Kim, MD, PhD1*, Katharine L. Lewis2, Juan Pablo Alderuccio, MD3, Hun Ju Lee, MD4, Enrico Derenzini, MD, PhD5*, Pier Luigi Zinzani, MD, PhD6, Marco Ladetto, MD7, Elizabeth H. Phillips8*, Hervé Ghesquieres, MD, PhD9*, François Lemonnier10*, Franck Morschhauser11, Ana Sureda Balari12, Antonia Rodriguez Izquierdo13*, Peter Borchmann, MD14, Matthew Weinstock15*, Jakub Svoboda, MD16, Emma Dean17*, Jelena Urosevic17*, Stefanie Meyer18*, Robert Chen19*, Richard Olsson20*, Kaitlyn Beyfuss21* and Graham P. Collins22

1Seoul National University Hospital, Seoul, Korea, Republic of (South)
2Linear Clinical Research, Sir Charles Gairdner Hospital and the University of Western Australia, Perth, Western Australia, Australia
3Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
4Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
5European Institute of Oncology, Milan, Italy
6University of Bologna, Istituto Di Ematologia, Bologna, Italy
7Ospedale Civile Ss. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
8University of Manchester, Christie NHS Foundation Trust and Division of Cancer Sciences, Manchester, United Kingdom
9Hospital Lyon Sud, Lyon, France
10Hopital Henri Mondor, Créteil, France
11Centre Hospitalier Universitaire de Lille - Hopital Claude Huriez, Lille, France
12Instituto Catalán de Oncología - Hospital Duran i Reynals, Barcelona, Spain
13Hospital Universitario 12 de Octubre, Madrid, Spain
14Universitätsklinikum Köln, Cologne, Germany
15Department of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA
16Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
17Oncology R&D, AstraZeneca, Cambridge, United Kingdom
18Hematology R&D, AstraZeneca, Boston, MA
19Hematology R&D, AstraZeneca, Cambridge, United Kingdom
20Hematology R&D, AstraZeneca, Mölndal, Sweden
21Hematology R&D, AstraZeneca, Mississauga, ON, Canada
22Oxford Cancer and Haematology Centre, Oxford, United Kingdom

Hun Ju Lee, MD1, Gregory Ravizzini, MD1*, Eslam Aboismail, MD1*, Jenna Wixom, BS2*, Jared Henderson, PhD1*, Luis E. Fayad, MD1, Sairah Ahmed, MD3, Ranjit Nair, MD3*, Jason R. Westin, MD1,4, Swaminathan P Iyer, MD5*, Chijioke Nze, MD, MPH3, Ajlan Al Zaki, MD, PhD6, Francisco Vega, MD, PhD7, Michael Wang, MD1, Christopher R. Flowers, MD, MS3 and Luis Malpica, MD3*

1The University of Texas MD Anderson Cancer Center, Houston, TX
2The University of Texas MD Anderson Cancer Center, HOUSTON, TX
3Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
4The University of Texas M D Anderson Cancer Center, Houston, TX
5University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Lymphoma/Myeloma and Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
7MD Anderson Cancer Center , Houston, TX

*signifies non-member of ASH